PanGenomic Health Inc - PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform PR Newswire LONDON
PanGenomic Health Inc on Wednesday said its net loss widened last year with rising expenses in several areas, but its chair said he was very pleased with its progress so far.
PanGenomic is based in. | May 3, 2023
DENVER, Dec. 12, 2022 (GLOBE NEWSWIRE) Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.